Here's how LINK.SPRINGER.COM makes money* and how much!

*Please read our disclaimer before using our estimates.
Loading...

LINK . SPRINGER . COM {}

  1. Analyzed Page
  2. Matching Content Categories
  3. CMS
  4. Monthly Traffic Estimate
  5. How Does Link.springer.com Make Money
  6. Keywords
  7. Topics
  8. Schema
  9. External Links
  10. Analytics And Tracking
  11. Libraries
  12. CDN Services

We are analyzing https://link.springer.com/article/10.1007/s00262-019-02466-x.

Title:
Autologous monocyte-derived DC vaccination combined with cisplatin in stage III and IV melanoma patients: a prospective, randomized phase 2 trial | Cancer Immunology, Immunotherapy
Description:
Background Autologous dendritic cell (DC) vaccines can induce tumor-specific T cells, but their effect can be counteracted by immunosuppressive mechanisms. Cisplatin has shown immunomodulatory effects in vivo which may enhance efficacy of DC vaccination. Methods This is a prospective, randomized, open-label phase 2 study (NCT02285413) including stage III and IV melanoma patients receiving 3 biweekly vaccinations of gp100 and tyrosinase mRNA-loaded monocyte-derived DCs with or without cisplatin. Primary objectives were to study immunogenicity and feasibility, and secondary objectives were to assess toxicity and survival. Results Twenty-two stage III and 32 stage IV melanoma patients were analyzed. Antigen-specific CD8+ T cells were found in 44% versus 67% and functional T cell responses in 28% versus 19% of skin-test infiltrating lymphocytes in patients receiving DC vaccination with and without cisplatin, respectively. Four patients stopped cisplatin because of toxicity and continued DC monotherapy. No therapy-related grade 3 or 4 adverse events occurred due to DC monotherapy. During combination therapy, one therapy-related grade 3 adverse event, decompensated heart failure due to fluid overload, occurred. The clinical outcome parameters did not clearly suggest significant differences. Conclusions Combination of DC vaccination and cisplatin in melanoma patients is feasible and safe, but does not seem to result in more tumor-specific T cell responses or improved clinical outcome, when compared to DC vaccination monotherapy.
Website Age:
28 years and 1 months (reg. 1997-05-29).

Matching Content Categories {📚}

  • Science
  • Health & Fitness
  • Education

Content Management System {📝}

What CMS is link.springer.com built with?

Custom-built

No common CMS systems were detected on Link.springer.com, and no known web development framework was identified.

Traffic Estimate {📈}

What is the average monthly size of link.springer.com audience?

🌠 Phenomenal Traffic: 5M - 10M visitors per month


Based on our best estimate, this website will receive around 7,642,828 visitors per month in the current month.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Link.springer.com Make Money? {💸}

We can't see how the site brings in money.

Many websites are intended to earn money, but some serve to share ideas or build connections. Websites exist for all kinds of purposes. This might be one of them. Link.springer.com might be making money, but it's not detectable how they're doing it.

Keywords {🔍}

patients, cells, melanoma, stage, cisplatin, vaccination, cell, article, google, scholar, iii, combination, tumor, treatment, cancer, responses, monotherapy, group, dendritic, fig, clinical, immune, response, cas, medical, trial, dcs, autologous, tissue, analysis, tyrosinase, compared, months, disease, research, van, effects, study, survival, adverse, therapy, proliferation, performed, klh, supplementary, skils, university, found, events, immunological,

Topics {✒️}

dendritic-cell based immunotherapy—focusing hla-dr−cd14+cd11b+cd33+ cells skin-test infiltrating lymphocytes autologous epstein–barr virus cis-dichlorodiammine-platinum versus dacarbazine formalin-fixed paraffin-embedded tumor-induced immune suppression skin-test infiltrating lymphocyte dendritic cell-based vaccination dendritic cell immunotherapy antibody-tsa complex removals ficoll-paque density centrifugation cd3+cd4+cd25+foxp3+ cells efficient antigen-presenting cells myeloid-derived suppressor cells tjitske duiveman-de boer effective anti-pd-1 mabs autologous dc vaccines clinical-grade dendritic cells phorbol myristate acetate-stimulated article download pdf conventional therapeutic interventions anti-hla-dr-bv510 antigen-specific t-cells anti-hla-dr-pe sided log-rank test anti-tumor immune response anti-hla-abc-pe anti-hla-dq-pe anna de goede common terminology criteria full access hla-type independent monitoring dc dendritic cell dendritic cell vaccination cisplatin-induced antitumor immunomodulation common adverse events keyhole limpet hemocyanin opal reagent incubations 5 ng/ml il-1β induce tumor-specific frequent adverse events adverse events leading melanoma-related death tumor antigen-specific chemo-immunotherapy strategies autologous dc vaccination privacy choices/manage cookies additional information publisher' primary antibody incubations

Schema {🗺️}

WebPage:
      mainEntity:
         headline:Autologous monocyte-derived DC vaccination combined with cisplatin in stage III and IV melanoma patients: a prospective, randomized phase 2 trial
         description:Autologous dendritic cell (DC) vaccines can induce tumor-specific T cells, but their effect can be counteracted by immunosuppressive mechanisms. Cisplatin has shown immunomodulatory effects in vivo which may enhance efficacy of DC vaccination. This is a prospective, randomized, open-label phase 2 study (NCT02285413) including stage III and IV melanoma patients receiving 3 biweekly vaccinations of gp100 and tyrosinase mRNA-loaded monocyte-derived DCs with or without cisplatin. Primary objectives were to study immunogenicity and feasibility, and secondary objectives were to assess toxicity and survival. Twenty-two stage III and 32 stage IV melanoma patients were analyzed. Antigen-specific CD8+ T cells were found in 44% versus 67% and functional T cell responses in 28% versus 19% of skin-test infiltrating lymphocytes in patients receiving DC vaccination with and without cisplatin, respectively. Four patients stopped cisplatin because of toxicity and continued DC monotherapy. No therapy-related grade 3 or 4 adverse events occurred due to DC monotherapy. During combination therapy, one therapy-related grade 3 adverse event, decompensated heart failure due to fluid overload, occurred. The clinical outcome parameters did not clearly suggest significant differences. Combination of DC vaccination and cisplatin in melanoma patients is feasible and safe, but does not seem to result in more tumor-specific T cell responses or improved clinical outcome, when compared to DC vaccination monotherapy.
         datePublished:2020-01-24T00:00:00Z
         dateModified:2020-01-24T00:00:00Z
         pageStart:477
         pageEnd:488
         license:http://creativecommons.org/licenses/by/4.0/
         sameAs:https://doi.org/10.1007/s00262-019-02466-x
         keywords:
            Dendritic cell
            Vaccination
            Cisplatin
            Melanoma
            Immunotherapy
            Oncology
            Immunology
            Cancer Research
         image:
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00262-019-02466-x/MediaObjects/262_2019_2466_Fig1_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00262-019-02466-x/MediaObjects/262_2019_2466_Fig2_HTML.jpg
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00262-019-02466-x/MediaObjects/262_2019_2466_Fig3_HTML.png
         isPartOf:
            name:Cancer Immunology, Immunotherapy
            issn:
               1432-0851
               0340-7004
            volumeNumber:69
            type:
               Periodical
               PublicationVolume
         publisher:
            name:Springer Berlin Heidelberg
            logo:
               url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
               type:ImageObject
            type:Organization
         author:
               name:Steve Boudewijns
               url:http://orcid.org/0000-0003-4201-3507
               affiliation:
                     name:Radboud University Medical Center
                     address:
                        name:Department of Medical Oncology, Radboud University Medical Center, Nijmegen, The Netherlands
                        type:PostalAddress
                     type:Organization
                     name:Radboud University Medical Center, Radboud Institute for Molecular Life Sciences
                     address:
                        name:Department of Tumor Immunology, Radboud University Medical Center, Radboud Institute for Molecular Life Sciences, Nijmegen, The Netherlands
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Martine Bloemendal
               url:http://orcid.org/0000-0001-9395-4214
               affiliation:
                     name:Radboud University Medical Center
                     address:
                        name:Department of Medical Oncology, Radboud University Medical Center, Nijmegen, The Netherlands
                        type:PostalAddress
                     type:Organization
                     name:Radboud University Medical Center, Radboud Institute for Molecular Life Sciences
                     address:
                        name:Department of Tumor Immunology, Radboud University Medical Center, Radboud Institute for Molecular Life Sciences, Nijmegen, The Netherlands
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Nienke de Haas
               url:http://orcid.org/0000-0002-4082-0498
               affiliation:
                     name:Radboud University Medical Center, Radboud Institute for Molecular Life Sciences
                     address:
                        name:Department of Tumor Immunology, Radboud University Medical Center, Radboud Institute for Molecular Life Sciences, Nijmegen, The Netherlands
                        type:PostalAddress
                     type:Organization
                     name:Radboud University Medical center
                     address:
                        name:Department of Pharmacy, Radboud University Medical center, Nijmegen, The Netherlands
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Harm Westdorp
               url:http://orcid.org/0000-0002-3336-4164
               affiliation:
                     name:Radboud University Medical Center
                     address:
                        name:Department of Medical Oncology, Radboud University Medical Center, Nijmegen, The Netherlands
                        type:PostalAddress
                     type:Organization
                     name:Radboud University Medical Center, Radboud Institute for Molecular Life Sciences
                     address:
                        name:Department of Tumor Immunology, Radboud University Medical Center, Radboud Institute for Molecular Life Sciences, Nijmegen, The Netherlands
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Kalijn F. Bol
               url:http://orcid.org/0000-0003-4165-2040
               affiliation:
                     name:Radboud University Medical Center
                     address:
                        name:Department of Medical Oncology, Radboud University Medical Center, Nijmegen, The Netherlands
                        type:PostalAddress
                     type:Organization
                     name:Radboud University Medical Center, Radboud Institute for Molecular Life Sciences
                     address:
                        name:Department of Tumor Immunology, Radboud University Medical Center, Radboud Institute for Molecular Life Sciences, Nijmegen, The Netherlands
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Gerty Schreibelt
               url:http://orcid.org/0000-0002-0156-8365
               affiliation:
                     name:Radboud University Medical Center, Radboud Institute for Molecular Life Sciences
                     address:
                        name:Department of Tumor Immunology, Radboud University Medical Center, Radboud Institute for Molecular Life Sciences, Nijmegen, The Netherlands
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Erik H. J. G. Aarntzen
               url:http://orcid.org/0000-0002-3809-0182
               affiliation:
                     name:Radboud University Medical Center, Radboud Institute for Molecular Life Sciences
                     address:
                        name:Department of Tumor Immunology, Radboud University Medical Center, Radboud Institute for Molecular Life Sciences, Nijmegen, The Netherlands
                        type:PostalAddress
                     type:Organization
                     name:Radboud University Medical Center
                     address:
                        name:Department of Radiology and Nuclear Medicine, Radboud University Medical Center, Nijmegen, The Netherlands
                        type:PostalAddress
                     type:Organization
               type:Person
               name:W. Joost Lesterhuis
               url:http://orcid.org/0000-0002-2718-276X
               affiliation:
                     name:Radboud University Medical Center, Radboud Institute for Molecular Life Sciences
                     address:
                        name:Department of Tumor Immunology, Radboud University Medical Center, Radboud Institute for Molecular Life Sciences, Nijmegen, The Netherlands
                        type:PostalAddress
                     type:Organization
                     name:University of Western Australia
                     address:
                        name:School of Biomedical Sciences, University of Western Australia, Crawley, Australia
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Mark A. J. Gorris
               url:http://orcid.org/0000-0003-3621-226X
               affiliation:
                     name:Radboud University Medical Center, Radboud Institute for Molecular Life Sciences
                     address:
                        name:Department of Tumor Immunology, Radboud University Medical Center, Radboud Institute for Molecular Life Sciences, Nijmegen, The Netherlands
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Alexandra Croockewit
               affiliation:
                     name:Radboud University Medical Center
                     address:
                        name:Department of Hematology, Radboud University Medical Center, Nijmegen, The Netherlands
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Lieke L. van der Woude
               affiliation:
                     name:Radboud University Medical Center, Radboud Institute for Molecular Life Sciences
                     address:
                        name:Department of Tumor Immunology, Radboud University Medical Center, Radboud Institute for Molecular Life Sciences, Nijmegen, The Netherlands
                        type:PostalAddress
                     type:Organization
                     name:Radboud University Medical Center
                     address:
                        name:Department of Pathology, Radboud University Medical Center, Nijmegen, The Netherlands
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Michelle M. van Rossum
               affiliation:
                     name:Radboud University Medical Center
                     address:
                        name:Department of Dermatology, Radboud University Medical Center, Nijmegen, The Netherlands
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Marieke Welzen
               affiliation:
                     name:Radboud University Medical center
                     address:
                        name:Department of Pharmacy, Radboud University Medical center, Nijmegen, The Netherlands
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Anna de Goede
               affiliation:
                     name:Radboud University Medical center
                     address:
                        name:Department of Pharmacy, Radboud University Medical center, Nijmegen, The Netherlands
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Stanleyson V. Hato
               affiliation:
                     name:Radboud University Medical Center, Radboud Institute for Molecular Life Sciences
                     address:
                        name:Department of Tumor Immunology, Radboud University Medical Center, Radboud Institute for Molecular Life Sciences, Nijmegen, The Netherlands
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Winette T. A. van der Graaf
               affiliation:
                     name:Radboud University Medical Center
                     address:
                        name:Department of Medical Oncology, Radboud University Medical Center, Nijmegen, The Netherlands
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Cornelis J. A. Punt
               url:http://orcid.org/0000-0003-0846-1445
               affiliation:
                     name:University of Amsterdam
                     address:
                        name:Department of Medical Oncology, Academic University Medical Center, University of Amsterdam, Amsterdam, The Netherlands
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Rutger H. T. Koornstra
               url:http://orcid.org/0000-0002-5446-755X
               affiliation:
                     name:Radboud University Medical Center
                     address:
                        name:Department of Medical Oncology, Radboud University Medical Center, Nijmegen, The Netherlands
                        type:PostalAddress
                     type:Organization
                     name:Rijnstate Hospital
                     address:
                        name:Oncological Center, Rijnstate Hospital, Arnhem, The Netherlands
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Winald R. Gerritsen
               url:http://orcid.org/0000-0003-1110-9119
               affiliation:
                     name:Radboud University Medical Center
                     address:
                        name:Department of Medical Oncology, Radboud University Medical Center, Nijmegen, The Netherlands
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Carl G. Figdor
               url:http://orcid.org/0000-0002-2366-9212
               affiliation:
                     name:Radboud University Medical Center, Radboud Institute for Molecular Life Sciences
                     address:
                        name:Department of Tumor Immunology, Radboud University Medical Center, Radboud Institute for Molecular Life Sciences, Nijmegen, The Netherlands
                        type:PostalAddress
                     type:Organization
               type:Person
               name:I. Jolanda M. de Vries
               url:http://orcid.org/0000-0002-8653-4040
               affiliation:
                     name:Radboud University Medical Center
                     address:
                        name:Department of Medical Oncology, Radboud University Medical Center, Nijmegen, The Netherlands
                        type:PostalAddress
                     type:Organization
                     name:Radboud University Medical Center, Radboud Institute for Molecular Life Sciences
                     address:
                        name:Department of Tumor Immunology, Radboud University Medical Center, Radboud Institute for Molecular Life Sciences, Nijmegen, The Netherlands
                        type:PostalAddress
                     type:Organization
               email:[email protected]
               type:Person
         isAccessibleForFree:1
         type:ScholarlyArticle
      context:https://schema.org
ScholarlyArticle:
      headline:Autologous monocyte-derived DC vaccination combined with cisplatin in stage III and IV melanoma patients: a prospective, randomized phase 2 trial
      description:Autologous dendritic cell (DC) vaccines can induce tumor-specific T cells, but their effect can be counteracted by immunosuppressive mechanisms. Cisplatin has shown immunomodulatory effects in vivo which may enhance efficacy of DC vaccination. This is a prospective, randomized, open-label phase 2 study (NCT02285413) including stage III and IV melanoma patients receiving 3 biweekly vaccinations of gp100 and tyrosinase mRNA-loaded monocyte-derived DCs with or without cisplatin. Primary objectives were to study immunogenicity and feasibility, and secondary objectives were to assess toxicity and survival. Twenty-two stage III and 32 stage IV melanoma patients were analyzed. Antigen-specific CD8+ T cells were found in 44% versus 67% and functional T cell responses in 28% versus 19% of skin-test infiltrating lymphocytes in patients receiving DC vaccination with and without cisplatin, respectively. Four patients stopped cisplatin because of toxicity and continued DC monotherapy. No therapy-related grade 3 or 4 adverse events occurred due to DC monotherapy. During combination therapy, one therapy-related grade 3 adverse event, decompensated heart failure due to fluid overload, occurred. The clinical outcome parameters did not clearly suggest significant differences. Combination of DC vaccination and cisplatin in melanoma patients is feasible and safe, but does not seem to result in more tumor-specific T cell responses or improved clinical outcome, when compared to DC vaccination monotherapy.
      datePublished:2020-01-24T00:00:00Z
      dateModified:2020-01-24T00:00:00Z
      pageStart:477
      pageEnd:488
      license:http://creativecommons.org/licenses/by/4.0/
      sameAs:https://doi.org/10.1007/s00262-019-02466-x
      keywords:
         Dendritic cell
         Vaccination
         Cisplatin
         Melanoma
         Immunotherapy
         Oncology
         Immunology
         Cancer Research
      image:
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00262-019-02466-x/MediaObjects/262_2019_2466_Fig1_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00262-019-02466-x/MediaObjects/262_2019_2466_Fig2_HTML.jpg
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00262-019-02466-x/MediaObjects/262_2019_2466_Fig3_HTML.png
      isPartOf:
         name:Cancer Immunology, Immunotherapy
         issn:
            1432-0851
            0340-7004
         volumeNumber:69
         type:
            Periodical
            PublicationVolume
      publisher:
         name:Springer Berlin Heidelberg
         logo:
            url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
            type:ImageObject
         type:Organization
      author:
            name:Steve Boudewijns
            url:http://orcid.org/0000-0003-4201-3507
            affiliation:
                  name:Radboud University Medical Center
                  address:
                     name:Department of Medical Oncology, Radboud University Medical Center, Nijmegen, The Netherlands
                     type:PostalAddress
                  type:Organization
                  name:Radboud University Medical Center, Radboud Institute for Molecular Life Sciences
                  address:
                     name:Department of Tumor Immunology, Radboud University Medical Center, Radboud Institute for Molecular Life Sciences, Nijmegen, The Netherlands
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Martine Bloemendal
            url:http://orcid.org/0000-0001-9395-4214
            affiliation:
                  name:Radboud University Medical Center
                  address:
                     name:Department of Medical Oncology, Radboud University Medical Center, Nijmegen, The Netherlands
                     type:PostalAddress
                  type:Organization
                  name:Radboud University Medical Center, Radboud Institute for Molecular Life Sciences
                  address:
                     name:Department of Tumor Immunology, Radboud University Medical Center, Radboud Institute for Molecular Life Sciences, Nijmegen, The Netherlands
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Nienke de Haas
            url:http://orcid.org/0000-0002-4082-0498
            affiliation:
                  name:Radboud University Medical Center, Radboud Institute for Molecular Life Sciences
                  address:
                     name:Department of Tumor Immunology, Radboud University Medical Center, Radboud Institute for Molecular Life Sciences, Nijmegen, The Netherlands
                     type:PostalAddress
                  type:Organization
                  name:Radboud University Medical center
                  address:
                     name:Department of Pharmacy, Radboud University Medical center, Nijmegen, The Netherlands
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Harm Westdorp
            url:http://orcid.org/0000-0002-3336-4164
            affiliation:
                  name:Radboud University Medical Center
                  address:
                     name:Department of Medical Oncology, Radboud University Medical Center, Nijmegen, The Netherlands
                     type:PostalAddress
                  type:Organization
                  name:Radboud University Medical Center, Radboud Institute for Molecular Life Sciences
                  address:
                     name:Department of Tumor Immunology, Radboud University Medical Center, Radboud Institute for Molecular Life Sciences, Nijmegen, The Netherlands
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Kalijn F. Bol
            url:http://orcid.org/0000-0003-4165-2040
            affiliation:
                  name:Radboud University Medical Center
                  address:
                     name:Department of Medical Oncology, Radboud University Medical Center, Nijmegen, The Netherlands
                     type:PostalAddress
                  type:Organization
                  name:Radboud University Medical Center, Radboud Institute for Molecular Life Sciences
                  address:
                     name:Department of Tumor Immunology, Radboud University Medical Center, Radboud Institute for Molecular Life Sciences, Nijmegen, The Netherlands
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Gerty Schreibelt
            url:http://orcid.org/0000-0002-0156-8365
            affiliation:
                  name:Radboud University Medical Center, Radboud Institute for Molecular Life Sciences
                  address:
                     name:Department of Tumor Immunology, Radboud University Medical Center, Radboud Institute for Molecular Life Sciences, Nijmegen, The Netherlands
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Erik H. J. G. Aarntzen
            url:http://orcid.org/0000-0002-3809-0182
            affiliation:
                  name:Radboud University Medical Center, Radboud Institute for Molecular Life Sciences
                  address:
                     name:Department of Tumor Immunology, Radboud University Medical Center, Radboud Institute for Molecular Life Sciences, Nijmegen, The Netherlands
                     type:PostalAddress
                  type:Organization
                  name:Radboud University Medical Center
                  address:
                     name:Department of Radiology and Nuclear Medicine, Radboud University Medical Center, Nijmegen, The Netherlands
                     type:PostalAddress
                  type:Organization
            type:Person
            name:W. Joost Lesterhuis
            url:http://orcid.org/0000-0002-2718-276X
            affiliation:
                  name:Radboud University Medical Center, Radboud Institute for Molecular Life Sciences
                  address:
                     name:Department of Tumor Immunology, Radboud University Medical Center, Radboud Institute for Molecular Life Sciences, Nijmegen, The Netherlands
                     type:PostalAddress
                  type:Organization
                  name:University of Western Australia
                  address:
                     name:School of Biomedical Sciences, University of Western Australia, Crawley, Australia
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Mark A. J. Gorris
            url:http://orcid.org/0000-0003-3621-226X
            affiliation:
                  name:Radboud University Medical Center, Radboud Institute for Molecular Life Sciences
                  address:
                     name:Department of Tumor Immunology, Radboud University Medical Center, Radboud Institute for Molecular Life Sciences, Nijmegen, The Netherlands
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Alexandra Croockewit
            affiliation:
                  name:Radboud University Medical Center
                  address:
                     name:Department of Hematology, Radboud University Medical Center, Nijmegen, The Netherlands
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Lieke L. van der Woude
            affiliation:
                  name:Radboud University Medical Center, Radboud Institute for Molecular Life Sciences
                  address:
                     name:Department of Tumor Immunology, Radboud University Medical Center, Radboud Institute for Molecular Life Sciences, Nijmegen, The Netherlands
                     type:PostalAddress
                  type:Organization
                  name:Radboud University Medical Center
                  address:
                     name:Department of Pathology, Radboud University Medical Center, Nijmegen, The Netherlands
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Michelle M. van Rossum
            affiliation:
                  name:Radboud University Medical Center
                  address:
                     name:Department of Dermatology, Radboud University Medical Center, Nijmegen, The Netherlands
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Marieke Welzen
            affiliation:
                  name:Radboud University Medical center
                  address:
                     name:Department of Pharmacy, Radboud University Medical center, Nijmegen, The Netherlands
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Anna de Goede
            affiliation:
                  name:Radboud University Medical center
                  address:
                     name:Department of Pharmacy, Radboud University Medical center, Nijmegen, The Netherlands
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Stanleyson V. Hato
            affiliation:
                  name:Radboud University Medical Center, Radboud Institute for Molecular Life Sciences
                  address:
                     name:Department of Tumor Immunology, Radboud University Medical Center, Radboud Institute for Molecular Life Sciences, Nijmegen, The Netherlands
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Winette T. A. van der Graaf
            affiliation:
                  name:Radboud University Medical Center
                  address:
                     name:Department of Medical Oncology, Radboud University Medical Center, Nijmegen, The Netherlands
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Cornelis J. A. Punt
            url:http://orcid.org/0000-0003-0846-1445
            affiliation:
                  name:University of Amsterdam
                  address:
                     name:Department of Medical Oncology, Academic University Medical Center, University of Amsterdam, Amsterdam, The Netherlands
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Rutger H. T. Koornstra
            url:http://orcid.org/0000-0002-5446-755X
            affiliation:
                  name:Radboud University Medical Center
                  address:
                     name:Department of Medical Oncology, Radboud University Medical Center, Nijmegen, The Netherlands
                     type:PostalAddress
                  type:Organization
                  name:Rijnstate Hospital
                  address:
                     name:Oncological Center, Rijnstate Hospital, Arnhem, The Netherlands
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Winald R. Gerritsen
            url:http://orcid.org/0000-0003-1110-9119
            affiliation:
                  name:Radboud University Medical Center
                  address:
                     name:Department of Medical Oncology, Radboud University Medical Center, Nijmegen, The Netherlands
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Carl G. Figdor
            url:http://orcid.org/0000-0002-2366-9212
            affiliation:
                  name:Radboud University Medical Center, Radboud Institute for Molecular Life Sciences
                  address:
                     name:Department of Tumor Immunology, Radboud University Medical Center, Radboud Institute for Molecular Life Sciences, Nijmegen, The Netherlands
                     type:PostalAddress
                  type:Organization
            type:Person
            name:I. Jolanda M. de Vries
            url:http://orcid.org/0000-0002-8653-4040
            affiliation:
                  name:Radboud University Medical Center
                  address:
                     name:Department of Medical Oncology, Radboud University Medical Center, Nijmegen, The Netherlands
                     type:PostalAddress
                  type:Organization
                  name:Radboud University Medical Center, Radboud Institute for Molecular Life Sciences
                  address:
                     name:Department of Tumor Immunology, Radboud University Medical Center, Radboud Institute for Molecular Life Sciences, Nijmegen, The Netherlands
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
      isAccessibleForFree:1
["Periodical","PublicationVolume"]:
      name:Cancer Immunology, Immunotherapy
      issn:
         1432-0851
         0340-7004
      volumeNumber:69
Organization:
      name:Springer Berlin Heidelberg
      logo:
         url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
         type:ImageObject
      name:Radboud University Medical Center
      address:
         name:Department of Medical Oncology, Radboud University Medical Center, Nijmegen, The Netherlands
         type:PostalAddress
      name:Radboud University Medical Center, Radboud Institute for Molecular Life Sciences
      address:
         name:Department of Tumor Immunology, Radboud University Medical Center, Radboud Institute for Molecular Life Sciences, Nijmegen, The Netherlands
         type:PostalAddress
      name:Radboud University Medical Center
      address:
         name:Department of Medical Oncology, Radboud University Medical Center, Nijmegen, The Netherlands
         type:PostalAddress
      name:Radboud University Medical Center, Radboud Institute for Molecular Life Sciences
      address:
         name:Department of Tumor Immunology, Radboud University Medical Center, Radboud Institute for Molecular Life Sciences, Nijmegen, The Netherlands
         type:PostalAddress
      name:Radboud University Medical Center, Radboud Institute for Molecular Life Sciences
      address:
         name:Department of Tumor Immunology, Radboud University Medical Center, Radboud Institute for Molecular Life Sciences, Nijmegen, The Netherlands
         type:PostalAddress
      name:Radboud University Medical center
      address:
         name:Department of Pharmacy, Radboud University Medical center, Nijmegen, The Netherlands
         type:PostalAddress
      name:Radboud University Medical Center
      address:
         name:Department of Medical Oncology, Radboud University Medical Center, Nijmegen, The Netherlands
         type:PostalAddress
      name:Radboud University Medical Center, Radboud Institute for Molecular Life Sciences
      address:
         name:Department of Tumor Immunology, Radboud University Medical Center, Radboud Institute for Molecular Life Sciences, Nijmegen, The Netherlands
         type:PostalAddress
      name:Radboud University Medical Center
      address:
         name:Department of Medical Oncology, Radboud University Medical Center, Nijmegen, The Netherlands
         type:PostalAddress
      name:Radboud University Medical Center, Radboud Institute for Molecular Life Sciences
      address:
         name:Department of Tumor Immunology, Radboud University Medical Center, Radboud Institute for Molecular Life Sciences, Nijmegen, The Netherlands
         type:PostalAddress
      name:Radboud University Medical Center, Radboud Institute for Molecular Life Sciences
      address:
         name:Department of Tumor Immunology, Radboud University Medical Center, Radboud Institute for Molecular Life Sciences, Nijmegen, The Netherlands
         type:PostalAddress
      name:Radboud University Medical Center, Radboud Institute for Molecular Life Sciences
      address:
         name:Department of Tumor Immunology, Radboud University Medical Center, Radboud Institute for Molecular Life Sciences, Nijmegen, The Netherlands
         type:PostalAddress
      name:Radboud University Medical Center
      address:
         name:Department of Radiology and Nuclear Medicine, Radboud University Medical Center, Nijmegen, The Netherlands
         type:PostalAddress
      name:Radboud University Medical Center, Radboud Institute for Molecular Life Sciences
      address:
         name:Department of Tumor Immunology, Radboud University Medical Center, Radboud Institute for Molecular Life Sciences, Nijmegen, The Netherlands
         type:PostalAddress
      name:University of Western Australia
      address:
         name:School of Biomedical Sciences, University of Western Australia, Crawley, Australia
         type:PostalAddress
      name:Radboud University Medical Center, Radboud Institute for Molecular Life Sciences
      address:
         name:Department of Tumor Immunology, Radboud University Medical Center, Radboud Institute for Molecular Life Sciences, Nijmegen, The Netherlands
         type:PostalAddress
      name:Radboud University Medical Center
      address:
         name:Department of Hematology, Radboud University Medical Center, Nijmegen, The Netherlands
         type:PostalAddress
      name:Radboud University Medical Center, Radboud Institute for Molecular Life Sciences
      address:
         name:Department of Tumor Immunology, Radboud University Medical Center, Radboud Institute for Molecular Life Sciences, Nijmegen, The Netherlands
         type:PostalAddress
      name:Radboud University Medical Center
      address:
         name:Department of Pathology, Radboud University Medical Center, Nijmegen, The Netherlands
         type:PostalAddress
      name:Radboud University Medical Center
      address:
         name:Department of Dermatology, Radboud University Medical Center, Nijmegen, The Netherlands
         type:PostalAddress
      name:Radboud University Medical center
      address:
         name:Department of Pharmacy, Radboud University Medical center, Nijmegen, The Netherlands
         type:PostalAddress
      name:Radboud University Medical center
      address:
         name:Department of Pharmacy, Radboud University Medical center, Nijmegen, The Netherlands
         type:PostalAddress
      name:Radboud University Medical Center, Radboud Institute for Molecular Life Sciences
      address:
         name:Department of Tumor Immunology, Radboud University Medical Center, Radboud Institute for Molecular Life Sciences, Nijmegen, The Netherlands
         type:PostalAddress
      name:Radboud University Medical Center
      address:
         name:Department of Medical Oncology, Radboud University Medical Center, Nijmegen, The Netherlands
         type:PostalAddress
      name:University of Amsterdam
      address:
         name:Department of Medical Oncology, Academic University Medical Center, University of Amsterdam, Amsterdam, The Netherlands
         type:PostalAddress
      name:Radboud University Medical Center
      address:
         name:Department of Medical Oncology, Radboud University Medical Center, Nijmegen, The Netherlands
         type:PostalAddress
      name:Rijnstate Hospital
      address:
         name:Oncological Center, Rijnstate Hospital, Arnhem, The Netherlands
         type:PostalAddress
      name:Radboud University Medical Center
      address:
         name:Department of Medical Oncology, Radboud University Medical Center, Nijmegen, The Netherlands
         type:PostalAddress
      name:Radboud University Medical Center, Radboud Institute for Molecular Life Sciences
      address:
         name:Department of Tumor Immunology, Radboud University Medical Center, Radboud Institute for Molecular Life Sciences, Nijmegen, The Netherlands
         type:PostalAddress
      name:Radboud University Medical Center
      address:
         name:Department of Medical Oncology, Radboud University Medical Center, Nijmegen, The Netherlands
         type:PostalAddress
      name:Radboud University Medical Center, Radboud Institute for Molecular Life Sciences
      address:
         name:Department of Tumor Immunology, Radboud University Medical Center, Radboud Institute for Molecular Life Sciences, Nijmegen, The Netherlands
         type:PostalAddress
ImageObject:
      url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
      name:Steve Boudewijns
      url:http://orcid.org/0000-0003-4201-3507
      affiliation:
            name:Radboud University Medical Center
            address:
               name:Department of Medical Oncology, Radboud University Medical Center, Nijmegen, The Netherlands
               type:PostalAddress
            type:Organization
            name:Radboud University Medical Center, Radboud Institute for Molecular Life Sciences
            address:
               name:Department of Tumor Immunology, Radboud University Medical Center, Radboud Institute for Molecular Life Sciences, Nijmegen, The Netherlands
               type:PostalAddress
            type:Organization
      name:Martine Bloemendal
      url:http://orcid.org/0000-0001-9395-4214
      affiliation:
            name:Radboud University Medical Center
            address:
               name:Department of Medical Oncology, Radboud University Medical Center, Nijmegen, The Netherlands
               type:PostalAddress
            type:Organization
            name:Radboud University Medical Center, Radboud Institute for Molecular Life Sciences
            address:
               name:Department of Tumor Immunology, Radboud University Medical Center, Radboud Institute for Molecular Life Sciences, Nijmegen, The Netherlands
               type:PostalAddress
            type:Organization
      name:Nienke de Haas
      url:http://orcid.org/0000-0002-4082-0498
      affiliation:
            name:Radboud University Medical Center, Radboud Institute for Molecular Life Sciences
            address:
               name:Department of Tumor Immunology, Radboud University Medical Center, Radboud Institute for Molecular Life Sciences, Nijmegen, The Netherlands
               type:PostalAddress
            type:Organization
            name:Radboud University Medical center
            address:
               name:Department of Pharmacy, Radboud University Medical center, Nijmegen, The Netherlands
               type:PostalAddress
            type:Organization
      name:Harm Westdorp
      url:http://orcid.org/0000-0002-3336-4164
      affiliation:
            name:Radboud University Medical Center
            address:
               name:Department of Medical Oncology, Radboud University Medical Center, Nijmegen, The Netherlands
               type:PostalAddress
            type:Organization
            name:Radboud University Medical Center, Radboud Institute for Molecular Life Sciences
            address:
               name:Department of Tumor Immunology, Radboud University Medical Center, Radboud Institute for Molecular Life Sciences, Nijmegen, The Netherlands
               type:PostalAddress
            type:Organization
      name:Kalijn F. Bol
      url:http://orcid.org/0000-0003-4165-2040
      affiliation:
            name:Radboud University Medical Center
            address:
               name:Department of Medical Oncology, Radboud University Medical Center, Nijmegen, The Netherlands
               type:PostalAddress
            type:Organization
            name:Radboud University Medical Center, Radboud Institute for Molecular Life Sciences
            address:
               name:Department of Tumor Immunology, Radboud University Medical Center, Radboud Institute for Molecular Life Sciences, Nijmegen, The Netherlands
               type:PostalAddress
            type:Organization
      name:Gerty Schreibelt
      url:http://orcid.org/0000-0002-0156-8365
      affiliation:
            name:Radboud University Medical Center, Radboud Institute for Molecular Life Sciences
            address:
               name:Department of Tumor Immunology, Radboud University Medical Center, Radboud Institute for Molecular Life Sciences, Nijmegen, The Netherlands
               type:PostalAddress
            type:Organization
      name:Erik H. J. G. Aarntzen
      url:http://orcid.org/0000-0002-3809-0182
      affiliation:
            name:Radboud University Medical Center, Radboud Institute for Molecular Life Sciences
            address:
               name:Department of Tumor Immunology, Radboud University Medical Center, Radboud Institute for Molecular Life Sciences, Nijmegen, The Netherlands
               type:PostalAddress
            type:Organization
            name:Radboud University Medical Center
            address:
               name:Department of Radiology and Nuclear Medicine, Radboud University Medical Center, Nijmegen, The Netherlands
               type:PostalAddress
            type:Organization
      name:W. Joost Lesterhuis
      url:http://orcid.org/0000-0002-2718-276X
      affiliation:
            name:Radboud University Medical Center, Radboud Institute for Molecular Life Sciences
            address:
               name:Department of Tumor Immunology, Radboud University Medical Center, Radboud Institute for Molecular Life Sciences, Nijmegen, The Netherlands
               type:PostalAddress
            type:Organization
            name:University of Western Australia
            address:
               name:School of Biomedical Sciences, University of Western Australia, Crawley, Australia
               type:PostalAddress
            type:Organization
      name:Mark A. J. Gorris
      url:http://orcid.org/0000-0003-3621-226X
      affiliation:
            name:Radboud University Medical Center, Radboud Institute for Molecular Life Sciences
            address:
               name:Department of Tumor Immunology, Radboud University Medical Center, Radboud Institute for Molecular Life Sciences, Nijmegen, The Netherlands
               type:PostalAddress
            type:Organization
      name:Alexandra Croockewit
      affiliation:
            name:Radboud University Medical Center
            address:
               name:Department of Hematology, Radboud University Medical Center, Nijmegen, The Netherlands
               type:PostalAddress
            type:Organization
      name:Lieke L. van der Woude
      affiliation:
            name:Radboud University Medical Center, Radboud Institute for Molecular Life Sciences
            address:
               name:Department of Tumor Immunology, Radboud University Medical Center, Radboud Institute for Molecular Life Sciences, Nijmegen, The Netherlands
               type:PostalAddress
            type:Organization
            name:Radboud University Medical Center
            address:
               name:Department of Pathology, Radboud University Medical Center, Nijmegen, The Netherlands
               type:PostalAddress
            type:Organization
      name:Michelle M. van Rossum
      affiliation:
            name:Radboud University Medical Center
            address:
               name:Department of Dermatology, Radboud University Medical Center, Nijmegen, The Netherlands
               type:PostalAddress
            type:Organization
      name:Marieke Welzen
      affiliation:
            name:Radboud University Medical center
            address:
               name:Department of Pharmacy, Radboud University Medical center, Nijmegen, The Netherlands
               type:PostalAddress
            type:Organization
      name:Anna de Goede
      affiliation:
            name:Radboud University Medical center
            address:
               name:Department of Pharmacy, Radboud University Medical center, Nijmegen, The Netherlands
               type:PostalAddress
            type:Organization
      name:Stanleyson V. Hato
      affiliation:
            name:Radboud University Medical Center, Radboud Institute for Molecular Life Sciences
            address:
               name:Department of Tumor Immunology, Radboud University Medical Center, Radboud Institute for Molecular Life Sciences, Nijmegen, The Netherlands
               type:PostalAddress
            type:Organization
      name:Winette T. A. van der Graaf
      affiliation:
            name:Radboud University Medical Center
            address:
               name:Department of Medical Oncology, Radboud University Medical Center, Nijmegen, The Netherlands
               type:PostalAddress
            type:Organization
      name:Cornelis J. A. Punt
      url:http://orcid.org/0000-0003-0846-1445
      affiliation:
            name:University of Amsterdam
            address:
               name:Department of Medical Oncology, Academic University Medical Center, University of Amsterdam, Amsterdam, The Netherlands
               type:PostalAddress
            type:Organization
      name:Rutger H. T. Koornstra
      url:http://orcid.org/0000-0002-5446-755X
      affiliation:
            name:Radboud University Medical Center
            address:
               name:Department of Medical Oncology, Radboud University Medical Center, Nijmegen, The Netherlands
               type:PostalAddress
            type:Organization
            name:Rijnstate Hospital
            address:
               name:Oncological Center, Rijnstate Hospital, Arnhem, The Netherlands
               type:PostalAddress
            type:Organization
      name:Winald R. Gerritsen
      url:http://orcid.org/0000-0003-1110-9119
      affiliation:
            name:Radboud University Medical Center
            address:
               name:Department of Medical Oncology, Radboud University Medical Center, Nijmegen, The Netherlands
               type:PostalAddress
            type:Organization
      name:Carl G. Figdor
      url:http://orcid.org/0000-0002-2366-9212
      affiliation:
            name:Radboud University Medical Center, Radboud Institute for Molecular Life Sciences
            address:
               name:Department of Tumor Immunology, Radboud University Medical Center, Radboud Institute for Molecular Life Sciences, Nijmegen, The Netherlands
               type:PostalAddress
            type:Organization
      name:I. Jolanda M. de Vries
      url:http://orcid.org/0000-0002-8653-4040
      affiliation:
            name:Radboud University Medical Center
            address:
               name:Department of Medical Oncology, Radboud University Medical Center, Nijmegen, The Netherlands
               type:PostalAddress
            type:Organization
            name:Radboud University Medical Center, Radboud Institute for Molecular Life Sciences
            address:
               name:Department of Tumor Immunology, Radboud University Medical Center, Radboud Institute for Molecular Life Sciences, Nijmegen, The Netherlands
               type:PostalAddress
            type:Organization
      email:[email protected]
PostalAddress:
      name:Department of Medical Oncology, Radboud University Medical Center, Nijmegen, The Netherlands
      name:Department of Tumor Immunology, Radboud University Medical Center, Radboud Institute for Molecular Life Sciences, Nijmegen, The Netherlands
      name:Department of Medical Oncology, Radboud University Medical Center, Nijmegen, The Netherlands
      name:Department of Tumor Immunology, Radboud University Medical Center, Radboud Institute for Molecular Life Sciences, Nijmegen, The Netherlands
      name:Department of Tumor Immunology, Radboud University Medical Center, Radboud Institute for Molecular Life Sciences, Nijmegen, The Netherlands
      name:Department of Pharmacy, Radboud University Medical center, Nijmegen, The Netherlands
      name:Department of Medical Oncology, Radboud University Medical Center, Nijmegen, The Netherlands
      name:Department of Tumor Immunology, Radboud University Medical Center, Radboud Institute for Molecular Life Sciences, Nijmegen, The Netherlands
      name:Department of Medical Oncology, Radboud University Medical Center, Nijmegen, The Netherlands
      name:Department of Tumor Immunology, Radboud University Medical Center, Radboud Institute for Molecular Life Sciences, Nijmegen, The Netherlands
      name:Department of Tumor Immunology, Radboud University Medical Center, Radboud Institute for Molecular Life Sciences, Nijmegen, The Netherlands
      name:Department of Tumor Immunology, Radboud University Medical Center, Radboud Institute for Molecular Life Sciences, Nijmegen, The Netherlands
      name:Department of Radiology and Nuclear Medicine, Radboud University Medical Center, Nijmegen, The Netherlands
      name:Department of Tumor Immunology, Radboud University Medical Center, Radboud Institute for Molecular Life Sciences, Nijmegen, The Netherlands
      name:School of Biomedical Sciences, University of Western Australia, Crawley, Australia
      name:Department of Tumor Immunology, Radboud University Medical Center, Radboud Institute for Molecular Life Sciences, Nijmegen, The Netherlands
      name:Department of Hematology, Radboud University Medical Center, Nijmegen, The Netherlands
      name:Department of Tumor Immunology, Radboud University Medical Center, Radboud Institute for Molecular Life Sciences, Nijmegen, The Netherlands
      name:Department of Pathology, Radboud University Medical Center, Nijmegen, The Netherlands
      name:Department of Dermatology, Radboud University Medical Center, Nijmegen, The Netherlands
      name:Department of Pharmacy, Radboud University Medical center, Nijmegen, The Netherlands
      name:Department of Pharmacy, Radboud University Medical center, Nijmegen, The Netherlands
      name:Department of Tumor Immunology, Radboud University Medical Center, Radboud Institute for Molecular Life Sciences, Nijmegen, The Netherlands
      name:Department of Medical Oncology, Radboud University Medical Center, Nijmegen, The Netherlands
      name:Department of Medical Oncology, Academic University Medical Center, University of Amsterdam, Amsterdam, The Netherlands
      name:Department of Medical Oncology, Radboud University Medical Center, Nijmegen, The Netherlands
      name:Oncological Center, Rijnstate Hospital, Arnhem, The Netherlands
      name:Department of Medical Oncology, Radboud University Medical Center, Nijmegen, The Netherlands
      name:Department of Tumor Immunology, Radboud University Medical Center, Radboud Institute for Molecular Life Sciences, Nijmegen, The Netherlands
      name:Department of Medical Oncology, Radboud University Medical Center, Nijmegen, The Netherlands
      name:Department of Tumor Immunology, Radboud University Medical Center, Radboud Institute for Molecular Life Sciences, Nijmegen, The Netherlands

External Links {🔗}(155)

Analytics and Tracking {📊}

  • Google Tag Manager

Libraries {📚}

  • Clipboard.js
  • Prism.js

CDN Services {📦}

  • Crossref

4.33s.